Chia Tai Enterprises International Limited (HKG:3839)

Market Cap	2.32B +461.3%
Revenue (ttm)	3.68B +12.4%
Net Income	235.26M +67.9%
EPS	0.93
Shares Out	253.33M
PE Ratio	9.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	101,120
Open	9.15
Previous Close	9.15
Day's Range	8.90 - 9.27
52-Week Range	1.74 - 10.15
Beta	3.99
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About HKG:3839

Chia Tai Enterprises International Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments: Biotech Business and Investment Business. The Biochemical segment is engaged in the manufacture and/or sale of animal health products and chlortetracycline, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance efficiency under the Shihao and Citifac brand names. The I...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 900
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3839

Financial Performance

In 2025, HKG:3839's revenue was $535.91 million, an increase of 74.14% compared to the previous year's $307.75 million. Earnings were $32.06 million, an increase of 187.03%.

Financial numbers in USD